FS Collins

6.7k total citations · 1 hit paper
50 papers, 2.2k citations indexed

About

FS Collins is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, FS Collins has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Hematology and 15 papers in Genetics. Recurrent topics in FS Collins's work include Hemoglobinopathies and Related Disorders (13 papers), Acute Myeloid Leukemia Research (8 papers) and DNA and Nucleic Acid Chemistry (5 papers). FS Collins is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Acute Myeloid Leukemia Research (8 papers) and DNA and Nucleic Acid Chemistry (5 papers). FS Collins collaborates with scholars based in United States, Netherlands and United Kingdom. FS Collins's co-authors include A K Hajra, Cisca Wijmenga, David R. Engelke, Susan A. Tarlé, Thomas J. Sferra, James Koh, S M Weissman, Deborah L. Gumucio, Todd A. Gray and David Shelton and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

FS Collins

49 papers receiving 2.1k citations

Hit Papers

Cystic fibrosis: molecular biology and therapeutic implic... 1992 2026 2003 2014 1992 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
FS Collins United States 25 1.1k 619 405 372 349 50 2.2k
Walter W. Noll United States 21 770 0.7× 298 0.5× 146 0.4× 255 0.7× 507 1.5× 43 2.0k
Jeffery L. Cole United States 17 989 0.9× 2.1k 3.3× 139 0.3× 350 0.9× 506 1.4× 19 3.4k
Mariko Eguchi Japan 24 832 0.8× 221 0.4× 845 2.1× 249 0.7× 170 0.5× 123 2.1k
Janette Lamb United States 24 838 0.8× 168 0.3× 475 1.2× 659 1.8× 487 1.4× 45 2.6k
Noriko Hosoya Japan 22 1.2k 1.1× 135 0.2× 255 0.6× 152 0.4× 435 1.2× 53 2.2k
C. Zurcher Netherlands 29 922 0.8× 252 0.4× 514 1.3× 150 0.4× 318 0.9× 91 2.7k
Claude Besmond France 26 952 0.9× 304 0.5× 99 0.2× 141 0.4× 286 0.8× 72 1.9k
F. Brok‐Simoni Israel 21 584 0.5× 115 0.2× 362 0.9× 286 0.8× 141 0.4× 70 1.4k
Lionel Blanc United States 28 1.5k 1.4× 285 0.5× 276 0.7× 404 1.1× 90 0.3× 82 2.5k
Jean Luc Laı̈ France 29 1.3k 1.2× 206 0.3× 1.5k 3.7× 708 1.9× 201 0.6× 71 3.1k

Countries citing papers authored by FS Collins

Since Specialization
Citations

This map shows the geographic impact of FS Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FS Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FS Collins more than expected).

Fields of papers citing papers by FS Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FS Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FS Collins. The network helps show where FS Collins may publish in the future.

Co-authorship network of co-authors of FS Collins

This figure shows the co-authorship network connecting the top 25 collaborators of FS Collins. A scholar is included among the top collaborators of FS Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FS Collins. FS Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonkman, Marcel F., Hendri H. Pas, Sandra Klingberg, et al.. (2006). Homozygosity for an intragenic deletion in the gene encoding collagen XVII, COL17A1 : 823delA results in lethality in a family with non-herlitz junctional epidermolysis bullosa. Data Archiving and Networked Services (DANS). 126. 38–38. 2 indexed citations
2.
Agarwal, Sunita, Peter C. Scacheri, Elizabeth A. Novotny, et al.. (2005). Menin Molecular Interactions: Insights into Normal Functions and Tumorigenesis. Hormone and Metabolic Research. 37(6). 369–374. 96 indexed citations
3.
Collins, FS. (1999). Genetics: an explosion of knowledge is transforming clinical practice.. PubMed. 54(1). 41–7; quiz 48. 24 indexed citations
4.
Hajra, A K, et al.. (1996). Transforming Properties of the Leukemic Inv(16) Fusion Gene CBFB-MYH11. Current topics in microbiology and immunology. 211. 289–298. 4 indexed citations
5.
Hajra, A K, et al.. (1995). Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia [see comments]. Blood. 85(9). 2289–2302. 170 indexed citations
6.
Collins, FS, et al.. (1995). Case: responding to a request for genetic testing that is still in the lab.. PubMed. 4(3). 387–400. 1 indexed citations
7.
Marlton, Paula, David F. Claxton, EH Estey, et al.. (1995). Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood. 85(3). 772–779. 74 indexed citations
8.
Liu, Pu, Nancy E. Seidel, David M. Bodine, et al.. (1994). Acute Myeloid Leukemia with Inv(16) Produces a Chimeric Transcription Factor with a Myosin Heavy Chain Tail. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 547–553. 28 indexed citations
9.
Gutmann, David H., et al.. (1994). Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP.. PubMed. 9(2). 349–57. 23 indexed citations
10.
Claxton, David F., Paula Marlton, J Hester, et al.. (1994). Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood. 83(7). 1750–1756. 8 indexed citations
11.
Rotman, Galit, Lina Vanagaite, FS Collins, & Yosef Shiloh. (1994). Three dinucleotide repeat polymorphisms at the ataxia-telangiectasia locus.. PubMed. 3(11). 2079–2079. 15 indexed citations
12.
Hajra, A K, David F. Claxton, Paula Marlton, et al.. (1993). A Fusion Between Transcription Factor Cbf-Beta-Pebp2-Beta and a Myosin Heavy-Chain Is Generated by the Chromosome-16 Inversion in Acute Myelomonocytic Leukemia M4eo. The American Journal of Human Genetics. 53(3). 243–243.
13.
Collins, FS. (1992). Cystic fibrosis: molecular biology and therapeutic implications. Science. 256(5058). 774–779. 638 indexed citations breakdown →
14.
Collins, FS. (1992). Identifying human disease genes by positional cloning.. PubMed. 86. 149–64. 11 indexed citations
15.
Gumucio, Deborah L., Todd A. Gray, Susan A. Tarlé, et al.. (1992). Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes.. Molecular and Cellular Biology. 12(11). 4919–4929. 149 indexed citations
16.
Walker, A.P., FS Collins, Teepu Siddique, et al.. (1990). D21S194, a jump clone from D21S16. Nucleic Acids Research. 18(7). 1931–1931. 5 indexed citations
18.
Metherall, James E., FS Collins, J. Pan, S M Weissman, & BG Forget. (1986). Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron.. The EMBO Journal. 5(10). 2551–2557. 40 indexed citations
19.
Collins, FS, et al.. (1985). Analysis of mutations associated with deletion and nondeletion hereditary persistence of fetal hemoglobin.. PubMed. 191. 107–24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026